Fig. 1From: Spatial metabolomics on liver cirrhosis to hepatocellular carcinoma progressionSchematics of using the AFADESI-MSI method to detect spatial distributions of metabolites in the healthy control (HC), HBV relative liver cirrhosis (LC) and liver cancer (HCC) samplesBack to article page